Treasurer of the State of North Carolina’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.74M | Hold |
20,883
| – | – | 0.01% | 712 |
|
|
2026
Q1 | $3.6M | Buy |
20,883
+447
| +2% | +$82.9K | 0.01% | 699 |
|
|
2025
Q4 | $4.08M | Sell |
20,436
-1,492
| -7% | -$271K | 0.01% | 672 |
|
|
2025
Q3 | $3.43M | Sell |
21,928
-855
| -4% | -$136K | 0.01% | 747 |
|
|
2025
Q2 | $3.46M | Sell |
22,783
-593
| -3% | -$79.1K | 0.01% | 758 |
|
|
2025
Q1 | $3.52M | Buy |
23,376
+920
| +4% | +$154K | 0.01% | 705 |
|
|
2024
Q4 | $4.14M | Sell |
22,456
-17,654
| -44% | -$3.4M | 0.02% | 648 |
|
|
2024
Q3 | $7.9M | Buy |
40,110
+7,790
| +24% | +$1.62M | 0.03% | 478 |
|
|
2024
Q2 | $6.68M | Buy |
32,320
+4,346
| +16% | +$985K | 0.03% | 499 |
|
|
2024
Q1 | $7.58M | Buy |
27,974
+150
| +0.5% | +$35.8K | 0.03% | 464 |
|
|
2023
Q4 | $6.58M | Buy |
27,824
+4,178
| +18% | +$822K | 0.03% | 481 |
|
|
2023
Q3 | $4.63M | Sell |
23,646
-968
| -4% | -$199K | 0.03% | 547 |
|
|
2023
Q2 | $5.17M | Buy |
24,614
+1,860
| +8% | +$370K | 0.03% | 528 |
|
|
2023
Q1 | $4.59M | Buy |
22,754
+150
| +0.7% | +$34K | 0.03% | 545 |
|
|
2022
Q4 | $4.92M | Buy |
22,604
+310
| +1% | +$67.7K | 0.03% | 518 |
|
|
2022
Q3 | $4.39M | Buy |
22,294
+270
| +1% | +$58.3K | 0.03% | 533 |
|
|
2022
Q2 | $4.71M | Buy |
22,024
+2,996
| +16% | +$732K | 0.03% | 524 |
|
|
2022
Q1 | $5.4M | Buy |
19,028
+960
| +5% | +$296K | 0.03% | 498 |
|
|
2021
Q4 | $6.81M | Buy |
18,068
+120
| +0.7% | +$46.6K | 0.04% | 441 |
|
|
2021
Q3 | $7.41M | Buy |
17,948
+599
| +3% | +$249K | 0.04% | 404 |
|
|
2021
Q2 | $6.42M | Sell |
17,349
-570
| -3% | -$190K | 0.04% | 443 |
|
|
2021
Q1 | $5.19M | Sell |
17,919
-40
| -0.2% | -$11.1K | 0.03% | 489 |
|
|
2020
Q4 | $4.49M | Buy |
17,959
+40
| +0.2% | +$9.53K | 0.03% | 510 |
|
|
2020
Q3 | $4.06M | Sell |
17,919
-20
| -0.1% | -$4.15K | 0.03% | 486 |
|
|
2020
Q2 | $3.13M | Sell |
17,939
-1,950
| -10% | -$311K | 0.03% | 524 |
|
|
2020
Q1 | $2.51M | Buy |
19,889
+8,265
| +71% | +$1.24M | 0.02% | 553 |
|
|
2019
Q4 | $1.78M | Buy |
11,624
+100
| +0.9% | +$13.8K | 0.01% | 625 |
|
|
2019
Q3 | $1.52M | Sell |
11,524
-7,820
| -40% | -$1.05M | 0.01% | 658 |
|
|
2019
Q2 | $2.75M | Sell |
19,344
-758
| -4% | -$103K | 0.02% | 684 |
|
|
2019
Q1 | $2.92M | Buy |
20,102
+167
| +0.8% | +$21.9K | 0.02% | 644 |
|
|
2018
Q4 | $2.26M | Buy |
19,935
+382
| +2% | +$47.8K | 0.02% | 679 |
|
|
2018
Q3 | $2.63M | Buy |
19,553
+7,651
| +64% | +$944K | 0.02% | 691 |
|
|
2018
Q2 | $1.34M | Buy |
11,902
+7,525
| +172% | +$814K | 0.01% | 770 |
|
|
2018
Q1 | $467K | Buy |
+4,377
| New | +$472K | 0.01% | 857 |
|
Other funds holding CRL
AI
Treasurer of the State of North Carolina's CRL Position: Q2 2026 in Review
Treasurer of the State of North Carolina held its Charles River Laboratories (CRL) position steady in Q2 2026 at 20,883 shares worth $4.74M. The position accounts for 0.01% of the portfolio, ranked #712.
Treasurer of the State of North Carolina first reported a position in CRL in Q1 2018 and has held it in 34 quarters since. The position peaked at $7.9M in Q3 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Treasurer of the State of North Carolina held 20,883 shares of Charles River Laboratories worth $4.74M as of Q2 2026.
- Treasurer of the State of North Carolina left its Charles River Laboratories share count unchanged in Q2 2026.
- Charles River Laboratories made up 0.01% of Treasurer of the State of North Carolina's portfolio in Q2 2026, its #712 holding.
- Treasurer of the State of North Carolina first reported a position in Charles River Laboratories in Q1 2018 and has held it in 34 quarters since.
- Treasurer of the State of North Carolina's Charles River Laboratories position peaked at $7.9M in Q3 2024.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Treasurer of the State of North Carolina's 13F filing for Q2 2026, filed 14 Aug 2026.